chr11-108293330-ATACT-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.4632_4635delCTTA(p.Tyr1544fs) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y1544Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
- ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- familial ovarian cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
- gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.4632_4635delCTTA | p.Tyr1544fs | frameshift_variant | Exon 31 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Familial cancer of breast Pathogenic:3
- -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
- -
Ataxia-telangiectasia syndrome Pathogenic:2
This sequence change creates a premature translational stop signal (p.Tyr1544*) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with ataxia-telangiectasia (PMID: 9887333, 10980530). This variant is also known as 4630del4. ClinVar contains an entry for this variant (Variation ID: 420011). For these reasons, this variant has been classified as Pathogenic. -
The following ACMG criteria is used: PVS1, PM2_Supporting (not reported in gnomAD), PM3_Supporting (detected in trans with a pathogenic variant). The variant has been described in several patients with with ataxia telangiectasia PMID: 12815592; 9887333; 10980530 -
not provided Pathogenic:2
- -
This deletion of four nucleotides is denoted ATM c.4632_4635delCTTA at the cDNA level and p.Tyr1544Ter (Y1544X) at the protein level. The normal sequence, with the bases that are deleted in brackets, is AATA[delCTTA]GTGA. The deletion creates a nonsense variant, which changes a Tyrosine to a premature stop codon. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. ATM c.4632_4635delCTTA, previously reported as ATM 4630del4, has been observed in at least three Ataxia-Telangiectasia families, one of which included an observation of this variant in the homozygous state in an individual with Ataxia-Telangiectasia (Sandoval 1999, Laake 2000). This variant is considered likely pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.4632_4635delCTTA pathogenic mutation, located in coding exon 30 of the ATM gene, results from a deletion of 4 nucleotides at nucleotide positions 4632 to 4635, causing a translational frameshift with a predicted alternate stop codon (p.Y1544*). This alteration has been reported in multiple individuals with a clinical diagnosis of ataxia telangiectasia (Sandoval N et al. Hum. Mol. Genet. 1999 Jan;8(1):69-79; Laake K et al. Hum. Mutat. 2000 Sep;16(3):232-46). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at